Company profile
SiteOne Therapeutics, Inc.
Transforming the Treatment of Pain
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- South San Francisco, CA
- Founded
- 2010
- LinkedIn followers
- 5,332
- Office locations
- 1
SiteOne Therapeutics, Inc. company summary
SiteOne Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in South San Francisco, CA, founded in 2010. On LinkedIn the company has around 6 employees and 5,332 followers.
What technology does SiteOne Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About SiteOne Therapeutics, Inc.
SiteOne Therapeutics is a biopharmaceutical company advancing a novel class of highly selective small molecule inhibitors targeting NaV1.7, NaV1.8, and other voltage-gated ion channels to treat sensory hyperexcitability disorders such as chronic cough, itch, and pain. Since its inception, SiteOne has been dedicated to the development of safe and effective pain therapeutics without the significant addiction potential and side effects of opioids. The company is also advancing additional novel drug candidates that exhibit precise selectivity for individual ion channel subtypes to treat other sensory hyperexcitability disorders such as chronic cough and chronic ocular surface pain.
Where is SiteOne Therapeutics, Inc. located?
SiteOne Therapeutics, Inc. lists 1 location.
Compare companies similar to SiteOne Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
SiteOne Therapeutics, Inc. siteonetherapeutics.com | Biotechnology Research | 6 | 2010 | South San Francisco, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about SiteOne Therapeutics, Inc.
What does SiteOne Therapeutics, Inc. do?
SiteOne Therapeutics is a biopharmaceutical company advancing a novel class of highly selective small molecule inhibitors targeting NaV1.7, NaV1.8, and other voltage-gated ion channels to treat sensory hyperexcitability disorders such as chronic cough, itch, and pain. Since its inception, SiteOne has been dedicated to the development of safe and effective pain therapeutics without the significant addiction potential and side effects of opioids. The company is also advancing additional novel drug candidates that exhibit precise selectivity for individual ion channel subtypes to treat other sensory hyperexcitability disorders such as chronic cough and chronic ocular surface pain.
How many employees does SiteOne Therapeutics, Inc. have?
SiteOne Therapeutics, Inc. has around 6 employees on LinkedIn.
Where is SiteOne Therapeutics, Inc. headquartered?
SiteOne Therapeutics, Inc. is headquartered in South San Francisco, CA.
When was SiteOne Therapeutics, Inc. founded?
SiteOne Therapeutics, Inc. was founded in 2010.
Build a lead list from companies like SiteOne Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.